Yüksel Ürün· @DrYukselUrun · X·· 16 小时前评分70
正文 · 原文
HARMONi-GI1: OS 14.9 vs 12.1 months.
Grade 3–4 AEs: 82% vs 72%.
A meaningful survival gain, with added toxicity.
@myESMO @OncoAlert @OpenMedicineHQ #ESMO26
39 浏览 · 1 赞 · 0 转发 · 0 回复
来源：Yüksel Ürün · x.com